
Chemical and Pharmaceutical Bulletin p. 557 - 561 (2012)
Update date:2022-07-30
Topics:
Kuo, Ping-Chung
Chen, Yi-Hsien
Leu, Yann-Lii
Huang, Chieh-Hung
Liao, Yu-Ren
Lee, E.-Jian
Yang, Mei-Lin
Wu, Tian-Shung
A new and efficient synthetic pathway employed the aldol condensation between the acetophenone (3) and vanillin derivative (4) resulted in the precursor chalcone intermediate (14). The target compound viscolin (1) could be afforded through the hydrogenation of the chalcone and followed by deprotection. The present strategy described the development of a more efficient procedure that allowed large-scale production of viscolin for the further research of biological activity both in vitro and in vivo.
View MoreSuzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Contact:+86 18616952870
Address:Area
Contact:+86-0592 5353131
Address:No.56 Guani Road Software Park 2,Siming District
Sichuan Sangao Biochemical Co., Ltd
Contact:+86-28-84874233
Address:19F, Bldg.2, Shudu Center, Tianfu 2nd St., Hi-tech zone, Chengdu 610041, Sichuan Province, China.
Melone Pharmaceutical Co., ltd
Contact:+86-411 82593920, 82593631
Address:No 232, JInma Roda, Development Zone, Dalian, China
Doi:10.1002/hlca.19970800509
(1997)Doi:10.1002/ejoc.201403634
(2015)Doi:10.1039/j39680001969
(1968)Doi:10.1016/S0968-0896(97)00137-5
(1997)Doi:10.1021/ja972690l
(1997)Doi:10.1007/BF00807595
(1997)